1 / 9

China Vaccine Market & Doses Forecast By Sector & Products (2019 - 2025)

According to Renub Reserach analysis China Vaccine Market size is projected to cross over US$ 9 Billion by 2025. Forecast By Sector & Products (2019 - 2025)

rresearch
Download Presentation

China Vaccine Market & Doses Forecast By Sector & Products (2019 - 2025)

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. China Vaccine Market China Vaccine Market

  2. Report Description and Highlights Vaccines are developed to address the public health needs. In China, vaccines are available through the government programmed called “Expanded Program on Immunization” at free for all children up to 14 years of age. However private sector vaccines such as Rabies Vaccine, Haemophilus Influenza Type B vaccine are also available in China but are usually paid for out-of- pocket as these are neither include in government EPI program nor government health insurance schemes. China Vaccine Market has great potential due to its vast population; so, its market size is projected to cross over US$ 9 Billion by 2025. Influenza Vaccine and China Vaccine Market

  3. China Vaccine Market China vaccine market is divided into public and private vaccine market. Public market is classified by Category 1 whereas and Private vaccines included in Category 2. Vaccines in the public market are regulated by PRC government and generally given free of cost by provincial CDC whereas private vaccine market is dominating by private vaccine companies. As a result, private vaccines prices are higher. China vaccine market has faced several scandals in past couple of years which certainly hinder the vaccine market growth. Renub Research report titled “China Vaccine Market & Doses Forecast By Sector (Private, Public), Disease Type (Meningococcal Meningitis, Pneumococcal, DTP, Ebola, Rabies, Others), Products (MCV4, MPSV4, MCV2-Hib, MCV2, MPSV2 and Men A, PCV13, PPV23, Others), Company (Sinopharm Group, Sinovac Biotech, Beijing Tiantan Biological Products Corp Ltd, Chongqing Zhifei Biological Products Co Ltd, Hualan Biological Engineering Inc, Liaoning Chengda Co Ltd, Walvax Biotechnology Co Ltd)” provides a complete analysis of China Vaccine Market. China Vaccine Market

  4. China Vaccine Market Sectors – Vaccine Market & Doses in China Public Private • • Disease Type Market - Meningococcal Meningitis, Pneumococcal and DTP Vaccine Market has significant Market Share in China Vaccine Market On the basis of disease type, Meningococcal meningitis, Pneumococcal and DTP Vaccine market is expected to control major portion of China vaccine market. Vaccine market in China is segmented into Meningococcal meningitis, Pneumococcal, DTP, Ebola, Rabies & Others. Request a free sample copy of the report: https://www.renub.com/request- sample-page.php?gturl=china-vaccine-market-p.php China Vaccine Market

  5. China Vaccine Market Forecast for China Vaccine Market Share (%) - by Products (2019 - 2025) Source: Renub Research Analysis Note: These are dummy figures; actual data given in the report China Vaccine Market

  6. China Vaccine Market Products – PCV13 Drives Vaccine Market in China In terms of products, PCV13 hold the maximum share of the China vaccine market. It is predicted that PCV13 will maintain their leading place during the forecasting period as well. Products included in this report are as follows: • MCV4 • MPSV4 • MCV2-Hib • MCV2 • MPSV2 and Men A • PCV13 • PPV23 Public and Private Vaccine Market & Doses This report provides the detailed analysis of public and private vaccine market in China. Report also provides private and public vaccine doses in China. China Vaccine Market

  7. China Vaccine Market Forecast for China Vaccine Market Share (%) - by Disease Type (2019 - 2025) Source: Renub Research Analysis Note: These are dummy figures; actual data given in the report China Vaccine Market

  8. China Vaccine Market Company Analysis All the companies covered in the report has been covered from the following points • Overview • Recent Development • Vaccine Pipeline • Revenue Analysis Key Company Covered – China Vaccine Market Sinopharm Group (China National Biotec Group Company Limited) Sinovac Biotech, Beijing Tiantan Biological Products Corp Ltd Chongqing Zhifei Biological Products Co Ltd Hualan Biological Engineering Inc Liaoning Chengda Co Ltd Walvax Biotechnology Co Ltd Request a free Brochure copy of the report: https://www.renub.com/request- brochure-page.php?gturl=biodegradable-plastic-market-p.php • • • • • • China Vaccine Market

  9. China Vaccine Market Browse Related Report : Adult Vaccine Market Europe Influenza Vaccine Market Contact Us Tel: +1-678-302-0700 (US), +91-120-421-9822 (INDIA) Email: info@renub.com China Vaccine Market

More Related